Strategic Partnerships Leverage SOFIE's licensing collaborations with GE HealthCare and strong investor signals to position the company as a preferred co development, manufacturing and distribution partner for theranostic radiopharmaceuticals across pharma and hospital networks.

CDMO and Dispensing Offer end to end radiopharmaceutical manufacturing and patient dose dispensing services to imaging centers, hospitals, and CROs, tapping into SOFIE's mature production and existing dispensing partnerships to shorten clinical trial timelines.

FAP Radiotracer Leader Capitalize on leadership in FAP PET radiotracer development and active licensing deals to upsell radiochemistry services, GMP production, regulatory support, and related imaging reagents to pharma and healthcare providers expanding theranostics portfolios.

Global Market Expansion Use growth signals from Jubilant Pharma investment and GE Healthcare licensing to pursue international partnerships, distributors, and regional CMOs in Europe and Asia for scaled manufacturing, distribution, and commercial uptake of radiopharmaceuticals.

Digital and Compliance Propose IT and logistics value adds such as inventory and cold chain management, regulatory documentation, ERP integration, and data analytics to improve operational efficiency for customers and attract larger biologics and pharma partners.